• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆行为障碍的诊断与治疗。

The Diagnosis and Treatment of Behavioral Disorders in Dementia.

出版信息

Dtsch Arztebl Int. 2017 Jun 30;114(26):447-454. doi: 10.3238/arztebl.2017.0447.

DOI:10.3238/arztebl.2017.0447
PMID:28705297
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5523798/
Abstract

BACKGROUND

Behavioral disorders such as aggressiveness, agitation, delusions, disinhibition, affect lability, and apathy arise in more than 90% of patients with dementia. Behavioral disorders are a major challenge and the greatest stress factor in everyday life for nursing personnel and for family members caring for the patient.

METHODS

This review is based on relevant publications retrieved by a selective literature search in the PubMed, Cochrane Library, and German S3 guideline databases with the search terms "behavioral disorders," "non-cognitive disorders," and "challenging behavior," in conjunction with "dementia" and "behavioral and psychological symptoms of dementia."

RESULTS

Behavioral disorders regularly accompany dementing illness and have identifiable and treatable somatic and environment-related causes. They should be treated symptomatically, both with non-pharmacological measures and with drugs. Memory therapy (d = 0.47), ergotherapy (d = 0.72), music therapy (d = 0.62), and physical exercise (d = 0.68) are effective, as are antidementia drugs (galantamine: p = 0.04, donepezil: p = 0.01, rivastigmine: p = 0.02, memantine: p = 0.004). Risperidone is the drug of choice to combat agitation and aggressiveness (d = 0.33) as well as dementia and hallucinations (d = 0.5). Citalopram can be recommended for the treatment of depression in patients with dementia (p = 0.05).

CONCLUSION

Because of an improved evidence base, the latest version of the German S3 guideline on the diagnosis and treatment of dementia places greater emphasis on non-pharmacological treatments for behavioral disorders in dementia than it did in the past. The global efficacy of such treatments against behavioral disorders is well documented. Nonetheless, because of the heterogeneity of interventions and varying standards of assessment, the evidence for the utility of certain specific methods in the treatment of specific behavioral disorders is still limited. More research is needed in this area.

摘要

背景

超过 90%的痴呆症患者会出现行为障碍,如攻击性、激越、妄想、抑制障碍、情绪不稳和淡漠。这些行为障碍是护理人员和照顾患者的家庭成员日常生活中的主要挑战和最大压力因素。

方法

本综述基于通过选择性文献检索在 PubMed、Cochrane 图书馆和德国 S3 指南数据库中检索到的相关出版物,检索词为“行为障碍”、“非认知障碍”和“挑战性行为”,并与“痴呆”和“痴呆的行为和心理症状”结合使用。

结果

行为障碍常伴随痴呆症发生,且具有可识别的、可治疗的躯体和环境相关原因。应采用对症治疗,包括非药物治疗和药物治疗。记忆疗法(d = 0.47)、作业疗法(d = 0.72)、音乐疗法(d = 0.62)和体育锻炼(d = 0.68)均有效,抗痴呆药物也有效(加兰他敏:p = 0.04,多奈哌齐:p = 0.01,利伐斯的明:p = 0.02,美金刚:p = 0.004)。对于激越和攻击性行为(d = 0.33)以及痴呆和幻觉(d = 0.5),利培酮是治疗的首选药物。西酞普兰可用于治疗痴呆症患者的抑郁症(p = 0.05)。

结论

由于证据基础的改善,德国关于痴呆症诊断和治疗的最新版 S3 指南比以往更加重视痴呆症患者行为障碍的非药物治疗。这些治疗方法对行为障碍的总体疗效已得到充分证实。尽管如此,由于干预措施的异质性和评估标准的不同,某些特定方法治疗特定行为障碍的有效性证据仍然有限。该领域需要更多的研究。

相似文献

1
The Diagnosis and Treatment of Behavioral Disorders in Dementia.痴呆行为障碍的诊断与治疗。
Dtsch Arztebl Int. 2017 Jun 30;114(26):447-454. doi: 10.3238/arztebl.2017.0447.
2
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.胆碱酯酶抑制剂对阿尔茨海默病痴呆的行为和心理症状管理有效吗?对多奈哌齐、卡巴拉汀和加兰他敏随机、安慰剂对照试验的系统评价。
Int Psychogeriatr. 2009 Oct;21(5):813-24. doi: 10.1017/S1041610209990354. Epub 2009 Jun 19.
3
Cholinesterase inhibitors for Alzheimer's disease.用于治疗阿尔茨海默病的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593.
4
[Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].[对接受多奈哌齐、卡巴拉汀、加兰他敏和美金刚治疗的西班牙阿尔茨海默病患者抗痴呆药物持续治疗模式的回顾性比较分析]
Rev Neurol. 2006;43(8):449-53.
5
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.多奈哌齐、加兰他敏、利伐斯的明和美金刚治疗阿尔茨海默病的有效性和成本效果(技术评估第 111 号回顾):系统评价和经济模型。
Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210.
6
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
7
Galantamine improves sleep quality in patients with dementia.加兰他敏可改善痴呆症患者的睡眠质量。
Acta Neurol Belg. 2015 Dec;115(4):563-8. doi: 10.1007/s13760-015-0453-9. Epub 2015 Mar 17.
8
9
Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.当前特定治疗方法对阿尔茨海默病患者行为和心理症状的影响差异:一项 12 个月、随机、开放标签试验。
J Alzheimers Dis. 2014;39(3):477-85. doi: 10.3233/JAD-131190.
10
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.胆碱酯酶抑制剂和美金刚治疗痴呆的有效性:临床实践指南的证据综述
Ann Intern Med. 2008 Mar 4;148(5):379-97. doi: 10.7326/0003-4819-148-5-200803040-00009.

引用本文的文献

1
Developing an ontology of non-pharmacological treatment for emotional and mood disturbances in dementia.开发痴呆症情绪和心境障碍非药物治疗本体论。
Sci Rep. 2024 Jan 22;14(1):1937. doi: 10.1038/s41598-023-46226-5.
2
Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.阿尔茨海默病的药物基因组学:药物利用和开发的新策略。
Methods Mol Biol. 2022;2547:275-387. doi: 10.1007/978-1-0716-2573-6_13.
3
[Deprescribing of antipsychotic drugs for dementia : Recommendations for action on dose reduction and discontinuation attempts].[痴呆症抗精神病药物的减药:关于剂量减少和停药尝试的行动建议]
Nervenarzt. 2022 Sep;93(9):912-920. doi: 10.1007/s00115-022-01343-w. Epub 2022 Jun 30.
4
Personalized Management and Treatment of Alzheimer's Disease.阿尔茨海默病的个性化管理与治疗
Life (Basel). 2022 Mar 21;12(3):460. doi: 10.3390/life12030460.
5
[Challenging behavior in longterm care].[长期护理中的挑战性行为]
MMW Fortschr Med. 2021 Nov;163(Suppl 3):59-67. doi: 10.1007/s15006-021-0285-x.
6
Impact of Dementia-Related Behavioral Symptoms on Healthcare Resource Use and Caregiver Burden: Real-World Data from Europe and the United States.痴呆相关行为症状对医疗资源利用和照料者负担的影响:来自欧洲和美国的真实世界数据。
J Alzheimers Dis. 2021;81(4):1567-1578. doi: 10.3233/JAD-201483.
7
Relation among Caregivers' Burden, Abuse and Behavioural Disorder in People with Dementia.照料者负担、虐待与痴呆患者行为障碍的关系。
Int J Environ Res Public Health. 2021 Jan 31;18(3):1263. doi: 10.3390/ijerph18031263.
8
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels.阿尔茨海默病痴呆患者血清胆碱酯酶抑制剂浓度常低于推荐水平。
Front Pharmacol. 2020 May 21;11:691. doi: 10.3389/fphar.2020.00691. eCollection 2020.
9
Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy.老年人的精神药理学治疗:避免药物相互作用和多种药物治疗。
Dtsch Arztebl Int. 2019 Jul 22;116(29-30):508-518. doi: 10.3238/arztebl.2019.0508.
10
[Challenging behavior and pain in dementia : Experiences of nursing staff in an acute care hospital].[痴呆症中的挑战性行为与疼痛:急症医院护理人员的经历]
Schmerz. 2019 Jun;33(3):212-219. doi: 10.1007/s00482-019-0360-8.

本文引用的文献

1
Behavioural and psychological symptoms in general hospital patients with dementia, distress for nursing staff and complications in care: results of the General Hospital Study.一般医院痴呆患者的行为和心理症状、护理人员的痛苦和护理中的并发症:一般医院研究的结果。
Epidemiol Psychiatr Sci. 2018 Jun;27(3):278-287. doi: 10.1017/S2045796016001098. Epub 2017 Jan 9.
2
Supporting Families Living With Dementia in Rural Areas.支持农村地区患有痴呆症的家庭。
Dtsch Arztebl Int. 2016 Oct 14;113(41):681-687. doi: 10.3238/arztebl.2016.0681.
3
Aromatherapy for dementia.用于治疗痴呆症的芳香疗法。
Cochrane Database Syst Rev. 2014 Feb 25(2):CD003150. doi: 10.1002/14651858.CD003150.pub2.
4
Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus.在一个有糖尿病的老年的、由不同种族组成的队列中,低血糖与痴呆的相关性。
JAMA Intern Med. 2013 Jul 22;173(14):1300-6. doi: 10.1001/jamainternmed.2013.6176.
5
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.阿尔茨海默病患者使用非典型抗精神病药物的认知影响:CATIE-AD 的结果。
Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.
6
Pain treatment of agitation in patients with dementia: a systematic review.痴呆患者激越的疼痛治疗:系统评价。
Int J Geriatr Psychiatry. 2011 Oct;26(10):1012-8. doi: 10.1002/gps.2649. Epub 2011 Feb 9.
7
Potentially inappropriate medications in the elderly: the PRISCUS list.老年人潜在不适当用药:PRISCUS 清单。
Dtsch Arztebl Int. 2010 Aug;107(31-32):543-51. doi: 10.3238/arztebl.2010.0543. Epub 2010 Aug 9.
8
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.美金刚治疗帕金森病痴呆或路易体痴呆患者的随机、双盲、安慰剂对照试验。
Lancet Neurol. 2010 Oct;9(10):969-77. doi: 10.1016/S1474-4422(10)70194-0. Epub 2010 Aug 20.
9
Challenges in conducting qualitative research with individuals with dementia.对患有痴呆症的个体进行定性研究时面临的挑战。
Res Gerontol Nurs. 2009 Jan;2(1):6-11. doi: 10.3928/19404921-20090101-04.
10
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.老年普通人群中具有抗胆碱能特性的药物、认知功能减退与痴呆:三城市研究
Arch Intern Med. 2009 Jul 27;169(14):1317-24. doi: 10.1001/archinternmed.2009.229.